Snap shot view on anaemia in chronic kidney disease of uncertain aetiology.
anaemia
anaemia in chronic disease
chronic kidney disease of uncertain aetiology
inflammatory score
iron deficiency anaemia
Journal
Nephrology (Carlton, Vic.)
ISSN: 1440-1797
Titre abrégé: Nephrology (Carlton)
Pays: Australia
ID NLM: 9615568
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
accepted:
30
11
2018
pubmed:
14
12
2018
medline:
28
2
2020
entrez:
8
12
2018
Statut:
ppublish
Résumé
Anaemia is a well-known complication of chronic kidney disease but there are no published studies on the pattern of anaemia in chronic kidney disease of uncertain aetiology (CKDu). This study aims to find out the prevalence, causes and associations of anaemia in CKDu to identify any unique features which are different from already described anaemia in chronic kidney disease. All (119) biopsy-confirmed CKDu patients in two endemic clinics (Girandurukotte and Wilgamuwa) were selected as cases. Blood samples (10 mL) were collected from the peripheral veins into Potassium-Ethylenediaminetetraacetic acid (K-EDTA) tubes, plain tubes and Na-citrated tubes. Serum was separated immediately by centrifugation at 3000 rpm for 10 min. Spot urine samples were collected into empty, sterile, polypropylene urine containers. All analyses were performed in IBM spss statistics version 23 (IBM Corp, Armonk, New York). The overall prevalence of anaemia in 119 non-dialysis CKDu patients was 72.3% with the highest prevalence seen in females compared to males (P < 0.001). The prevalence of anaemia in CKDu patients with progression to renal failure was 66.7% - stage 1, 60% - stage 2, 50% - stage 3a, 95% - stage 3b, 79.2% - stage 4 and 100% - stage 5 (P = 0.005). Of CKDu patients, 44.3% had anaemia of chronic disease with iron deficiency. CKDu patients with anaemia had a high inflammatory score were seen in both early and late stages of CKDu. There were a similar proportion of patients with both early and late CKDu having unexplained anaemia. The current study showed a significant association of anaemia with disease severity among CKDu patients. Iron deficiency is a crucial aetiology factor of anaemia in CKDu and inflammation likely to effects adversely on anaemia of CKDu.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1033-1040Subventions
Organisme : NRC (National Research Council, SriLanka)
ID : TO 14-05
Informations de copyright
© 2018 Asian Pacific Society of Nephrology.
Références
Pavlovic NM. Balken endemic nephropathy-Current status and future perspectives. Clin. Kidney J. 2013; 6: 257-65.
Tohyama C, Shalikh ZA, Nogawa K, Kobayashi E, Honda R. Urinary metallothionein as a new index of renal dysfunction in “Itai-Itai” disease patients and other Japanese women environmentally exposed to cadmium. Arch. Toxicol. 1982; 50: 159-66.
Evans M, Elinder CG. Chronic renal failure from lead: Myth or evidence-based fact. Int. Soc. Nephrol. 2011; 79: 272-9.
Weaver VM, Fadrowski JJ, Jaar BG. Global dimensions of chronic kidney disease of unknown etiology (CKDu): A modern era environmental and/or occupational nephropathy? BMC Nephrol. 2015; 16: 145.
World Health Organization Report on Chronic Kidney Disease of Unknown Aetiology in SriLanka. Available from URL: http://www.lankaweb.com/news/items/2012/08/15/world-health-organization-who-report-on-chronic-kidney-disease-of-unknown-etiology-ckdu-in-sri-lanka/. (accessed 10 April 2013
Elledge MF, Redmon JH, Levine KE RJ Wickremasinghe, KP Wanigasariya, RJ Peiris. Chronic Kidney Disease of Unknown Etiology in Sri Lanka: Quest for Understanding and Global Implications. RTI Research Brief, RTI Press, May 2014. Available from URL: https://doi.org/10.3768/rtipress.2014.rb.0007.1405. (accessed 20 October 2014
Ranasinghe P, Perera YS, Makarim MF, Wijesinghe A, Wanigasuriya K. The costs in provision of haemodialysis in a developing country: A multi-centered study. BMC Nephrol. 2011; 12: 42.
Nanayakkara S, Komiya T, Tatnatunga N et al. Tubulointerstitial damage as the major pathological lesion in endemic chronic kidney disease among farmers in north Central Province of Sri Lanka: A cross-sectional study. Environ. Health Prev. Med. 2011; 17: 109-17.
Jayathilake N, Mendis S, Maheepala P, Mehta FR. Chronic kidney disease of uncertain aetiology: Prevalence and causative factors in a developing country. BMC Nephrol. 2013; 14: 180.
Bright R. Cases and observations: Illustration of renal disease accompanied by the secretion of albuminous urine. Guys Hosp. Rep. 1836; 1: 338.
KDOQI clinical practice guidelines and clinical practice recommendations for anaemia in chronic kidney disease. Am. J. Kidney Dis. 2006; 47: S11-S145.
Babitt JL, Lin HY. Mechanisms of anaemia in CKD. J. Am. Soc. Nephrol. 2012; 23: 1631-4.
Tsagalis G. Renal anaemia: A nephrologist's view. Hippokratia 2011; 15 (Suppl 1: 39-43.
Fernando WBNT, Rathnayake RMPM, Abeysundara HTK, Badurdeen Z and Nanayakkara N. A study to compare the prevalence of anaemia in Chronic Kidney Disease of uncertain etiology (CKD-u) patients in Girandurukotte and Wilgamuwa with Chronic Kidney Disease (CKD) patients in Kandy. 2017. 10th International Research Conference, General Sir John Kotelawala Defence University
Fernando WBNT, Rathnayake RMPM, Abeysundara HTK, et al. Prevalence of anaemia in CKD-u patients in Girandurukotte and Wilgamuwa. 2017. 10th International Research Conference, General Sir John Kotelawala Defence University
Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009; 150: 604-12.
Chapter 1: diagnosis and evaluation of anaemia in CKD. Kidney Int. Suppl. (2011) 2012; 2: 288-91.
Recasens M, López-Bermejo A, Ricart W, Vendrell J, Casamitjana R, Fernandez-Real JM. An inflammation score is better associated with basal than stimulated surrogate indexes of insulin resistance. J. Clin. Endocrinol. Metab. 2005; 90: 112-6.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney inter. 2013; 3: 1-150.
Jayatissa R, Hossain SM, Gunawardana S et al. Prevalence and associations of overweight among adult women in SL: An national survey. SriLanka J. Diabetes Endocrinol. Metab. 2012; 2: 61-8.
Smith REJ. The Clinical and economic burden of anaemia. Am. J. Manag. Care 2010; 16: 59-66.
Joanne B. Anaemia management in CKD. Pharm. Pract. 2006; 22: 1-25.
Rao DS, Shih MS, Mohini R. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in anaemia. N. Engl. J. Med. 1993; 328: 171-5.
Afshar R, Sanavi S, Salimi J, Ahmadzadeh M. Haematological profile of Chronic Kidney Disease (CKD) patients in iron in predialysis stages and after initiation of haemodialysis. Saudi J Kidney Transpl. 2010; 21: 368-71.
Suega K, Bakta M, Dharmayudha TG, Lukman JS, Suwitra K. Profile of anaemia in chronic renal failure patients: Comparison between predialyzed patients at the Division of Nephrology, Dpt of Internal Medicine, Songlah Hospital, Denpasar, Bali, Indonesia. Acta Med. Indones. 2005; 37: 190-4.
Poudel B, Yadav BK, Jha B, Raut KB, Pandeya DR. Prevalence and association of anaemia with CKD: A hospital based cross-sectional study from Nepal. Biomed. Res. 2013; 24: 99-103.
Ryu S-R, Park SK, Jung JY et al. The prevalence and management of anaemia in CKD patient: Result from the Korean cohort study for outcomes in patients with CKD (KNOW-CKD). J. Korean Med. Sci. 2017; 32: 249-56.
Stauffer ME, Fan T. Prevalence of anaemia in CKD in the United States. PLoS One 2014; 9: e84943.
Clage CM, Kiberd BA, Garg AX. Relationship between glomerular filtration rate and the prevalence of metabolic abnormalities: Results from the Third National health and Nutrition Examination Survey (NHANES III). Nephron Clin. Pract. 2007; 105: 178-84.
Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH. Progression of nephropathy in type 2 diabetic patients. Kidney Int. 2004; 66: 1596-605.
World Health Organization. The global prevalence of anaemia in 2011. Geneva: World Health Organization; 2015.
Johnson-Spear MA, Yip R. Haemoglobin difference between black and white women with comparable iron status: Justification for race-specific anaemia criteria. Am. J. Clin. Nutr. 1994; 60: 117-21.
Le CHH. The prevalence of anaemia and moderate-severe anaemia in the US population (NHANES 2003-2012). PLoS One 2016; 11: e0166635.
Hillman D, David LB, Edward MC. Hypothyroidism & anaemia related to fluoride in dairy cattle. J. Dairy Sci. 1979; 62: 416-23.
Kalantar ZK, Hoffken B, Wunsch H, Fink H, Kleiner M, Luft FC. Diagnosis of iron deficiency anaemia in renal failure patients during the post-erythropoietin era. Am. J. Kidney Dis. 1995; 26: 292-9.
Talib SH, Kulkarni SG, Gulwe VS, Mogal V. Role of iron deficiency anaemia in patients with CKD. IOSR J. Dental Med. Sci. 2015; 14: 102-5.
Silverberg DS, Wexler D, Blum M et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anaemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class and markedly reduces hospitalizations. JACC 2000; 35: 1737-44.
Spinowitz BS, Kausz AT, Baptista J et al. Ferumoxytol for treating iron deficiency anaemia in CKD. J. Am. Soc. Nephrol. 2008; 19: 1599-605.
Levin A, Bakris GL, Molitch M et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney Int. 2007; 71: 31-8.
Kovesdy CP, Anderson JE, Zadeh KK. Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD. Nephrol. Dial. Transpl. 2009; 24: 1232-7.
Bellasi A, Mandreoli M, Baldrati L et al. Chronic Kidney Disease progression and outcome according to serum phosphorous in mild-to-moderate kidney dysfunction. Clin. J. Am. Soc. Nephrol. 2011; 6: 883-91.